Attached files
| file | filename |
|---|---|
| EX-10.2 - SECOND AMENDMENT TO SEVERANCE AGREEMENT - ST JUDE MEDICAL, LLC | stjude20160702_10-2q2.htm |
| 10-Q - 10-Q - ST JUDE MEDICAL, LLC | stj-2016070210qq2.htm |
| EX-32.2 - CERTIFICATION OF CFO PURSUANT TO SECTION 906 - ST JUDE MEDICAL, LLC | stjude20160702_ex32-2q2.htm |
| EX-31.2 - CERTIFICATION OF CFO PURSUANT TO SECTION 302 - ST JUDE MEDICAL, LLC | stjude20160702_ex31-2q2.htm |
| EX-31.1 - CERTIFICATION OF CEO PURSUANT TO SECTION 302 - ST JUDE MEDICAL, LLC | stjude20160702_ex31-1q2.htm |
| EX-12 - COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES - ST JUDE MEDICAL, LLC | a20160702_ex12q2.htm |
| EX-10.1 - AMENDMENT TO SEVERANCE AGREEMENT - ST JUDE MEDICAL, LLC | stjude20160702_10-1q2.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of St. Jude Medical, Inc. (the Company) on Form 10-Q for the period ended July 2, 2016 as filed with the Securities and Exchange Commission (the Report), I, Michael T. Rousseau, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
/s/ MICHAEL T. ROUSSEAU | ||
Michael T. Rousseau | ||
President and Chief Executive Officer | ||
August 3, 2016 | ||